FATE THERAPEUTICS INC Investment Income, Interest
FATE THERAPEUTICS INC (FATE) reported Investment Income, Interest of $1.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-13
- FATE THERAPEUTICS INC investment income, interest for the quarter ending 2026-06-30 was $1.55M, a 46.76% decline year-over-year.
- FATE THERAPEUTICS INC investment income, interest for the quarter ending 2026-03-31 was $1.87M, a 44.03% decline year-over-year.
- FATE THERAPEUTICS INC investment income, interest for the quarter ending 2025-12-31 was $2.22M, a 42.69% decline year-over-year.
- FATE THERAPEUTICS INC investment income, interest for the quarter ending 2025-09-30 was $2.58M, a 41.98% decline year-over-year.
- FATE THERAPEUTICS INC investment income, interest for fiscal 2025 was $11.05M, a 36.07% decline from fiscal 2024.
- FATE THERAPEUTICS INC investment income, interest for fiscal 2024 was $17.29M, a 0.59% increase from fiscal 2023.
- FATE THERAPEUTICS INC investment income, interest for fiscal 2023 was $17.19M, a 194.18% increase from fiscal 2022.
- FATE THERAPEUTICS INC investment income, interest for fiscal 2022 was $5.84M, a 346.29% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 80 month | Investment Income, Interest 83 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.55M 10-Q · filed 2026-08-13 | $3.42M 10-Q · filed 2026-08-13 | $5.64M derived: sum of 3 quarters · filed 2026-08-13 | $8.22M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $1.87M 10-Q · filed 2026-05-13 | $4.09M derived: sum of 2 quarters · filed 2026-05-13 | $6.66M derived: sum of 3 quarters · filed 2026-05-13 | $9.58M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $2.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.79M derived: sum of 2 quarters · filed 2026-02-26 | $7.72M derived: sum of 3 quarters · filed 2026-08-13 | $11.05M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $2.58M 10-Q · filed 2025-11-13 | $5.50M derived: sum of 2 quarters · filed 2026-08-13 | $8.83M 10-Q · filed 2025-11-13 | $12.71M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $2.92M 10-Q · filed 2026-08-13 | $6.26M 10-Q · filed 2026-08-13 | $10.13M derived: sum of 3 quarters · filed 2026-08-13 | $14.57M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $3.34M 10-Q · filed 2026-05-13 | $7.21M derived: sum of 2 quarters · filed 2026-05-13 | $11.65M derived: sum of 3 quarters · filed 2026-05-13 | $16.48M derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $8.31M derived: sum of 2 quarters · filed 2026-02-26 | $13.14M derived: sum of 3 quarters · filed 2026-02-26 | $17.29M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $4.44M 10-Q · filed 2025-11-13 | $9.27M derived: sum of 2 quarters · filed 2025-11-13 | $13.41M 10-Q · filed 2025-11-13 | $17.83M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $4.83M 10-Q · filed 2025-08-12 | $8.98M 10-Q · filed 2025-08-12 | $13.39M derived: sum of 3 quarters · filed 2025-08-12 | $18.09M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $4.15M 10-Q · filed 2025-05-13 | $8.56M derived: sum of 2 quarters · filed 2025-05-13 | $13.26M derived: sum of 3 quarters · filed 2025-05-13 | $17.64M derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $9.11M derived: sum of 2 quarters · filed 2025-03-05 | $13.49M derived: sum of 3 quarters · filed 2025-03-05 | $17.19M 10-K · filed 2025-03-05 | ||
| 2023-09-30 | $4.70M 10-Q · filed 2024-11-12 | $9.08M derived: sum of 2 quarters · filed 2024-11-12 | $12.77M 10-Q · filed 2024-11-12 | $15.65M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $4.38M 10-Q · filed 2024-08-13 | $8.07M 10-Q · filed 2024-08-13 | $10.96M derived: sum of 3 quarters · filed 2024-08-13 | $12.74M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $3.69M 10-Q · filed 2024-05-09 | $6.57M derived: sum of 2 quarters · filed 2024-05-09 | $8.36M derived: sum of 3 quarters · filed 2024-05-09 | $9.12M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $2.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $4.67M derived: sum of 2 quarters · filed 2024-02-26 | $5.42M derived: sum of 3 quarters · filed 2024-02-26 | $5.84M 10-K · filed 2024-02-26 | ||
| 2022-09-30 | $1.79M 10-Q · filed 2023-11-08 | $2.54M derived: sum of 2 quarters · filed 2023-11-08 | $2.96M 10-Q · filed 2023-11-08 | $3.26M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | $757.00K 10-Q · filed 2023-08-08 | $1.18M 10-Q · filed 2023-08-08 | $1.47M derived: sum of 3 quarters · filed 2023-08-08 | $1.76M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $418.00K 10-Q · filed 2023-05-03 | $715.00K derived: sum of 2 quarters · filed 2023-05-03 | $1.00M derived: sum of 3 quarters · filed 2023-05-03 | $1.35M derived: sum of 4 quarters · filed 2023-05-03 | ||
| 2021-12-31 | $297.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $586.00K derived: sum of 2 quarters · filed 2023-02-28 | $932.00K derived: sum of 3 quarters · filed 2023-02-28 | $1.31M 10-K · filed 2023-02-28 | ||
| 2021-09-30 | $289.00K 10-Q · filed 2022-11-03 | $635.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.01M 10-Q · filed 2022-11-03 | $1.36M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | $346.00K 10-Q · filed 2022-08-03 | $723.00K 10-Q · filed 2022-08-03 | $1.07M derived: sum of 3 quarters · filed 2023-02-28 | $1.52M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | $377.00K 10-Q · filed 2022-05-04 | $723.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.17M derived: sum of 3 quarters · filed 2023-02-28 | $1.80M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $793.00K derived: sum of 2 quarters · filed 2023-02-28 | $1.43M derived: sum of 3 quarters · filed 2023-02-28 | $2.40M 10-K · filed 2023-02-28 | ||
| 2020-09-30 | $447.00K 10-Q · filed 2021-11-04 | $1.08M derived: sum of 2 quarters · filed 2021-11-04 | $2.05M 10-Q · filed 2021-11-04 | $3.37M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $635.00K 10-Q · filed 2021-08-04 | $1.61M 10-Q · filed 2021-08-04 | $2.92M derived: sum of 3 quarters · filed 2022-02-28 | $3.83M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-03-31 | $972.00K 10-Q · filed 2021-05-05 | $2.29M derived: sum of 2 quarters · filed 2022-02-28 | $3.20M derived: sum of 3 quarters · filed 2022-02-28 | $4.21M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2019-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $2.22M derived: sum of 2 quarters · filed 2022-02-28 | $3.24M derived: sum of 3 quarters · filed 2022-02-28 | $4.33M 10-K · filed 2022-02-28 | ||
| 2019-09-30 | $910.00K 10-Q · filed 2020-11-05 | $1.93M derived: sum of 2 quarters · filed 2020-11-05 | $3.02M 10-Q · filed 2020-11-05 | $4.16M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-06-30 | $1.01M 10-Q · filed 2020-08-05 | $2.11M 10-Q · filed 2020-08-05 | $3.25M derived: sum of 3 quarters · filed 2021-02-24 | $3.59M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2019-03-31 | $1.09M 10-Q · filed 2020-05-11 | $2.23M derived: sum of 2 quarters · filed 2021-02-24 | $2.57M derived: sum of 3 quarters · filed 2021-02-24 | $2.95M derived: sum of 4 quarters · filed 2021-02-24 | ||
| 2018-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $1.48M derived: sum of 2 quarters · filed 2021-02-24 | $1.86M derived: sum of 3 quarters · filed 2021-02-24 | $2.19M 10-K · filed 2021-02-24 | ||
| 2018-09-30 | $339.00K 10-Q · filed 2019-11-05 | $715.00K derived: sum of 2 quarters · filed 2019-11-05 | $1.05M 10-Q · filed 2019-11-05 | $1.21M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-06-30 | $376.00K 10-Q · filed 2019-08-06 | $707.00K 10-Q · filed 2019-08-06 | $866.00K derived: sum of 3 quarters · filed 2020-03-02 | $1.02M derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2018-03-31 | $331.00K 10-Q · filed 2019-05-07 | $490.00K derived: sum of 2 quarters · filed 2020-03-02 | $642.00K derived: sum of 3 quarters · filed 2020-03-02 | $779.00K derived: sum of 4 quarters · filed 2020-03-02 | ||
| 2017-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $311.00K derived: sum of 2 quarters · filed 2020-03-02 | $448.00K derived: sum of 3 quarters · filed 2020-03-02 | $559.00K 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $152.00K 10-Q · filed 2018-11-01 | $289.00K derived: sum of 2 quarters · filed 2018-11-01 | $400.00K 10-Q · filed 2018-11-01 | $443.00K derived: sum of 4 quarters · filed 2019-03-05 | ||
| 2017-06-30 | $137.00K 10-Q · filed 2018-08-06 | $248.00K 10-Q · filed 2018-08-06 | $291.00K derived: sum of 3 quarters · filed 2019-03-05 | $328.00K derived: sum of 4 quarters · filed 2019-03-05 | ||
| 2017-03-31 | $111.00K 10-Q · filed 2018-05-10 | $154.00K derived: sum of 2 quarters · filed 2019-03-05 | $191.00K derived: sum of 3 quarters · filed 2019-03-05 | $222.00K derived: sum of 4 quarters · filed 2019-03-05 | ||
| 2016-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-05 | $80.00K derived: sum of 2 quarters · filed 2019-03-05 | $111.00K derived: sum of 3 quarters · filed 2019-03-05 | $138.00K 10-K · filed 2019-03-05 | ||
| 2016-09-30 | $37.00K 10-Q · filed 2017-11-01 | $68.00K derived: sum of 2 quarters · filed 2017-11-01 | $95.00K 10-Q · filed 2017-11-01 | $98.00K derived: sum of 4 quarters · filed 2018-03-05 | ||
| 2016-06-30 | $31.00K 10-Q · filed 2017-08-14 | $58.00K 10-Q · filed 2017-08-14 | $61.00K derived: sum of 3 quarters · filed 2018-03-05 | $65.00K derived: sum of 4 quarters · filed 2018-03-05 | ||
| 2016-03-31 | $27.00K 10-Q · filed 2017-05-15 | $30.00K derived: sum of 2 quarters · filed 2018-03-05 | $34.00K derived: sum of 3 quarters · filed 2018-03-05 | $36.00K derived: sum of 4 quarters · filed 2018-03-05 | ||
| 2015-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05 | $7.00K derived: sum of 2 quarters · filed 2018-03-05 | $9.00K derived: sum of 3 quarters · filed 2018-03-05 | $10.00K 10-K · filed 2018-03-05 | ||
| 2015-09-30 | $4.00K 10-Q · filed 2016-11-07 | $6.00K derived: sum of 2 quarters · filed 2016-11-07 | $7.00K 10-Q · filed 2016-11-07 | $8.00K derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | $2.00K 10-Q · filed 2016-08-08 | $3.00K 10-Q · filed 2016-08-08 | $4.00K derived: sum of 3 quarters · filed 2017-03-16 | $4.00K derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-03-31 | $1.00K 10-Q · filed 2016-05-09 | $2.00K derived: sum of 2 quarters · filed 2017-03-16 | $2.00K derived: sum of 3 quarters · filed 2017-03-16 | $3.00K derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.00K derived: sum of 2 quarters · filed 2017-03-16 | $2.00K derived: sum of 3 quarters · filed 2017-03-16 | $2.00K 10-K · filed 2017-03-16 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $1.00K derived: sum of 2 quarters · filed 2015-11-03 | $1.00K 10-Q · filed 2015-11-03 | |||
| 2014-06-30 | $1.00K 10-Q · filed 2015-08-05 | $1.00K 10-Q · filed 2015-08-05 | ||||
| 2014-03-31 | $192.00K 10-Q · filed 2014-05-13 | |||||
| 2013-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $5.00K derived: sum of 2 quarters · filed 2016-03-03 | $5.00K derived: sum of 3 quarters · filed 2016-03-03 | $6.00K 10-K · filed 2016-03-03 | $192.00K 10-K · filed 2014-03-17 | |
| 2013-09-30 | $2.00K 10-Q · filed 2014-11-12 | $2.00K derived: sum of 2 quarters · filed 2014-11-12 | $3.00K 10-Q · filed 2014-11-12 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $1.00K 10-Q · filed 2014-08-12 | ||||
| 2013-03-31 | $1.00K 10-Q · filed 2014-05-13 | |||||
| 2012-12-31 | $1.00K 10-K · filed 2015-03-12 | |||||
| 2011-12-31 | $2.00K 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |